drugset

drugset / Trial / NCT00735839

V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)

NCT00735839 ↗

Phase 1 Completed 40 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindPrevention

Summary

This study is to evaluate the safety and immunogenicity of V710 in Japanese male subjects.

Timeline

Start: 2008-03
Primary completion: 2008-06
Completion: 2008-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	V710	Vaccine	60 ug	Other

Indications